Ratings Supremex Inc.

Equities

SXP

CA86863R1055

Market Closed - Toronto S.E. Other stock markets 03:59:47 2024-04-26 pm EDT			5-day change	1st Jan Change
3.93 ^CAD	-1.75%		+0.77%	-7.96%

Feb. 22	Transcript : Supremex Inc., Q4 2023 Earnings Call, Feb 22, 2024
Feb. 22	Supremex's Q4 Adjusted Profit, Revenue Falls; Dividend Declared; Provides Outlook	MT

Summary

On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

The company shows low valuation levels, with an enterprise value at 0.58 times its sales.
Given the positive cash flows generated by its business, the company's valuation level is an asset.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
Over the past four months, analysts' average price target has been revised downwards significantly.

Ratings chart - Surperformance

Sector: Paper Products

	1st Jan change	Capi.	ESG Refinitiv
SUPREMEX INC.	-7.96%	73.68M	-
UPM-KYMMENE OYJ	-3.17%	18.78B	B
SUZANO S.A.	+7.10%	14.99B	A-
SVENSKA CELLULOSA AKTIEBOLAGET SCA	+5.03%	10.18B	A
HOLMEN AB	-1.67%	6.08B	B
EMPRESAS CMPC S.A.	+8.82%	4.88B	A-
THE NAVIGATOR COMPANY	+16.91%	3.15B	B+
CENTURY TEXTILES AND INDUSTRIES LIMITED	+63.21%	2.67B	B-
XIANHE CO.,LTD.	+12.02%	1.76B	-
SAPPI LIMITED	+15.48%	1.52B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes